Search

Leumas Raises $2.2M to Disrupt Pharma Manufacturing with Smart Robotics

Deeptech manufacturing startup Leumas® has raised $2.2 million in a seed funding round led by Capital 2B, a deeptech-focused fund backed by Info Edge and Temasek, with participation from Capital-A and Anicut Capital. The funds will be used to expand Leumas’ R&D capabilities, scale its on-demand manufacturing infrastructure, and launch pilot factory deployments for wellness and pharma brands.

Founded in 2016 by Subhajit Biswas and Nitesh K., Leumas delivers Factory-as-a-Service solutions through software-defined, modular robot factories. These systems blend AI-led robotics, vision-based quality control, and autonomous operations to streamline manufacturing from development to commercial production—helping brands scale faster, maintain product quality, and reduce operational risk.

Leumas’ cyber-physical manufacturing platform transforms traditional production lines into software-driven, intelligent systems that ensure optimal output and regulatory compliance. This innovation addresses the massive global outsourced development and manufacturing market, projected to exceed $400 billion by 2030 in the pharma and wellness sectors.

In the past year, Leumas has co-developed its technology with leading wellness brands, helping scale 120+ products across India, the US, and the MENA region. The company has also signed strategic agreements with pharma and food research institutions to build dedicated, modular factory capacities.

\r\n

Latest Stories